Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid Tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/21326629

Download in:

View as

General Info

PMID
21326629